1. Levy S. B. (2000) Antibiotic and antiseptic resistance: impact on public health. J. Pediatr. Infect. Dis., 19, 120–122; DOI :http://dx.doi.org/10.1097/00006454-200010001-00008.
2. Ardiansah B. (2017) Pharmaceutical importance of pyrazoline derivatives. J. Pharm. Sci. Res., 9, 1958-1960; DOI: https://doi.org/10.1080/104265090968118.
3. Rostami H., Shiri L., Khani Z. (2022) Recent advances in the synthesis of pyrazole scaffolds via nanoparticles: A review. Tetrahedron 110, 132-688; DOI: https://doi.org/10.1016/j.tet.2022.132688.
4. Andres Arias-Gomez., Andres Godoy., Jaime Portilla. (2021) Functional Pyrazolo[1,5- a]pyrimidines: Current approaches in synthetic transformations and uses as an antitumor scaffold. Molecules., 26, 1-35; DOI: https://doi.org/10.3390/molecules26092708.
5. Beena Varghese., Saleh N. Al-Busafi., FakhrEldin O. Suliman., Salma M. Z. Al-Kindy. (2017)., Unveiling a versatile heterocycle: pyrazoline - a review. RSC Adv., 7, 1-18; DOI: 10.1039/C7RA08939B.
6. Aly A. Abd-Ella., Saoud A. Metwally., Mokhtar A. Abd ul-Malik., Yasser A. El-Ossaily., Fathy M. Abd Elraze., Safwat A. Aref., Youssra A. Naffea., Shaban A. A. Abdel-Raheem. (2022) A review on recent advances for the synthesis of bioactive pyrazolinone and pyrazolidinedione derivatives. Curr. Chem. Lett., 11, 157–172; DOI: 10.5267/j.ccl.2022.2.004.
7. Rashad A. E., Sayed H. H., Shamroukh H. H., Awad H. M. (2005) Preparation of some fused pyridopyrimidine and pyridothienotriazine derivatives for biological evaluation. Phosphorus Sulfur Silicon Relat. Elem., 180, 2767-2777; DOI: https://doi.org/10.1016/j.bmc.2008.06.054.
8. Rashad A. E., Shamroukh A. H., Hegab M. I., Awad H. M. (2005) Synthesis of some biologically active pyrazoles and C-Nucleosides. Acta Chim. Slov., 52, 429-434; Corpus ID: 49573412.
9. Zakia E. A., Solimana H. A., Hiekalb O. A., Rashada A. E. (2006) Pyrazolopyranopyrimidines as a class of anti-Inflammatory agents magdy. Zeitschrift für Naturforschung C., 61, 1-5; DOI: https://doi.org/10.1515/znc-2006-1-201.
10. Rashad A. E., Hegab M. I., Abdel-Megeid R. E., Fatahala N. A., AbdelMegeid F. M. E. (2008) Synthesis and antiviral evaluation of some new pyrazole and fused pyrazolopyrimidine derivatives. Bioorg. Med. Chem., 16, 7102-7106; DOI: https://doi.org/10.1016/j.bmc.2008.06.054.
11. Khobragade C. N., Bodade R. G., Konda S. G., Dawane B. S., Manwar A.V. (2010) Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives. Eur. J. Med. Chem., 45, 1635-1638; DOI: https://doi.org/10.1016/j.ejmech.2009.12.040.
12. Raffa D., Maggio B., Plescia F., Cascioferro S., Raimondi M. V., Plescia S., Cusimano M. G. (2009) Pyrazolo[3,4-d]pyrimidine derivatives as COX-2 selective inhibitors synthesis and molecular modeling studies. M. Arch. Pharm., 342, 321-326; DOI: https://doi.org/10.1002/ardp.200800140.
13. Schenone S., Bruno O., Ranise A., Bondavalli F., Brullo C., Fossa P., Mosti L., Menozzi G., Carraro F., Naldini A., Bernini C., Manetti F., Botta M. (2004) New pyrazolo[3,4-d]pyrimidines, endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation. Bioorg. Med. Chem. Lett., 14, 2511-2517; DOI: 10.1016/j.bmcl.2004.03.013.
14. Ghorab M. M., Ragab F. A., Alqasoumi S. I., Alafeefy A. M., Aboulmagd S. A. (2010) Synthesis of some new pyrazolo[3,4-d]pyrimidine derivatives of expected anticancer and radio protective activity. Eur. J. Med. Chem., 45, 171-178; DOI: https://doi.org/10.1016/j.ejmech.2009.09.039.
15. El-Enany M. M., Kamel M. M., Khalil O. M., El-Nassan H. B. (2010) Synthesis and antitumor activity of novel 6-aryl and 6-alkylpyrazolo[3,4-d]pyrimidin-4-one derivatives. Eur. J. Med. Chem., 45, 5286-5291; DOI: https://doi.org/10.1016/j.ejmech.2010.08.048.
16. Patricia D. Sauzem., Pablo Machado., Maribel A. Rubin., Gabriela da S. Sant Anna., Henrique B. Faber b., Alessandra H. de Souza. (2008) Design and microwave-assisted synthesis of 5-trifluoromethyl-4,5-dihydro-1H-pyrazoles Novel agents with analgesic and anti-inflammatory properties. Eur. J. Med. Chem., 43, 1237-1247; DOI: https://doi.org/10.1016/j.ejmech.2007.07.018.
17. Vinay Pogaku., Kiran Gangarapu., Srinivas Basavoju., Kiran Kumar Tatapudi., Suresh Babu Katragadda. (2019) Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors. Bioorg. Chem., 93, 1-10; DOI: https://doi.org/10.1016/j.bioorg.2019.103307.
18. Yuh Wen Ho. (2005) Synthesis of some new azo pyrazolo[1,5-a]pyrimidine-thieno[2,3-b]pyridine derivatives and their application as disperse dye. Dye. Pigment., 64, 223-230; DOI: https://doi.org/10.1016/j.dyepig.2004.06.007.
19. Monika Pokladko-Kowar., Ewa Gondek., Andrzej Danel., Tomasz Uchacz., Paweł Szlachcic., Katarzyna Wojtasik., Paweł Karasiński. (2022) Trifluoromethyl substituted derivatives of pyrazoles as materials for photovoltaic and electroluminescent applications. Crystals., 12(3), 1-20; DOI: https://doi.org/10.3390/cryst12030434.
20. Tsai P. C., Wang. (2007) A facile synthesis of some novel pyrazolo[1,5-a]pyrimidine heterocyclic disazo dyes and an evaluation of their solvatochromic behavior. Dye. Pigment., 74, 578-584; DOI: https://doi.org/10.1016/j.dyepig.2006.03.022.
21. Levy S. B., Marshall B. (2004) Antibacterial resistance worldwide Cause, challenges and responses. Nat. Med., 10, S122-S129; Doi:10.1038/nm1145.
22. Whitener C. J., Park S. Y., Browne F. A., Parent L. J. (2004) Derivatives of a vancomycin-resistant staphylococcus aureus strain isolated at herhey medical center. Clin. Infect. Dis., 38, 1049-1055.
23. Ajmal Bhat R. (2017) Biological activity of pyrimidine derivativies: a review, Org. Med. Chem., 2, 1–4; DOI: 10.19080/OMCIJ.2017.02.555581.
24. Jin. C., Liang Y. J., He. H., Fu L. (2011) Synthesis and antitumor activity of ureas containing pyrimidinyl group. Eur. J. Med. Chem., 46, 429-432; DOI:10.1016/j.ejmech.2010.11.026.
25. Obaiah N., Bodke Y. D., Telkar S. (2020) Synthesis of 3-[(1H-benzimidazol-2- ylsulfanyl)(aryl)methyl]-4-hydroxycoumarin derivatives as potent bioactive molecules. Chemistry Select., 5, 178–184; DOI:10.1002/slct.20190347.
26. Mabry. J., Ganem. B. (2006) Studies on the biginelli reaction a mild and selective route to 3,4-dihydropyrimidin-2(1H)-ones via enamine intermediates. Tetrahedron Lett., 47, 55–56; DOI:10.1016/j.tetlet.2005.10.124.
27. Kumar A., Maurya R. A. (2007) Synthesis of polyhydroquinoline derivatives through unsymmetric hantzsch reaction using organocatalysts. Tetrahedron Lett., 63, 1946–1952; DOI:10.1016/j.tet.2006.12.074.
28. List. B., Pojarliev. P., Biller W. T., Martin H. J. (2002) The Proline-catalyzed direct asymmetric three-component mannich reaction scope, optimization, and application to the highly enantioselective synthesis of 1,2-amino alcohols. J. Am. Chem. Soc., 124, 827–833; DOI:10.1021/ja0174231.
29. Anam Ansari., Abad Ali., Mohd Asif., Shamsuzzaman. (2017) Review: biologically active pyrazole derivatives. New J. Chem., 41, 16-41; DOI: 10.1039/c6nj03181a.
30. Metwally S. A. M., Abdel-Moneim M. I., El-Ossaily Y. A., Radwa I. A., Abou-Hadeed K. (2010) Synthesis and Crystal structure of some 3,5-pyrazolidinediones. Chem. Heterocycl. Compd., 46 (4), 426-437.
31. Kamal A., Sastry K. N. V., Chandrasekhar D., Mani G. S., Adiyala P. R., Nanubolu J. B., Singarapu K. J., Maurya R. A. (2015) One-Pot, Three-Component Approach to the Synthesis of 3,4,5-Trisubstituted Pyrazoles. J. Org. Chem., 80, 4325-4335; DOI: 10.1021/jo502946g.
32. Sukanya S. H., Talavara Venkatesh., Aditya Rao S. J., Shivakumara N., Muthipeedika Nibin Joy. (2021) Facile synthesis of some 5-(3-substituted-thiophene)-pyrimidine derivatives and their pharmacological and computational studies. Chim. Techno Acta., 8, 1-13; DOI: 10.15826/chimtech.2021.8.4.01
33. Nirmala.S.Naik., Lokesh A. Shastri., Shrinivas D. Joshi., Sheshagiri R. Dixit. (2017) 3,4-Dihydropyrimidinone-coumarin analogues as a new class of selective agent against S.aureus: Synthesis, biological evaluation and molecular modeling study. Bioorg. Med. Chem., 25, 1413-1422; DOI: https://doi.org/10.1016/j.bmc.2017.01.001.
34. Hong Wang., Jinhong Zheng., Weijie Xu., Cheng Chen., Duncan Wei., Wenxiu Ni., Ying Pan. (2017) A New Series of cytotoxic pyrazoline derivatives as potential anticancer agents that induce cell cycle arrest and apoptosis. Molecules., 22, 1-14; DOI: 10.3390/molecules22101635.
35. Havrylyuk D., Zimenkovsky B., Vasylenko O., Gzella A., Lesyk R. (2012) Synthesis of new 4-thiazolidinone-pyrazoline and isatin based conjugates with promising antitumor activity. J. Med. Chem., 55, 8630–8641; https://doi.org/10.1021/jm300789g.
36. Sequist L. V., James Chih-Hsin Yang., Nobuyuki Yamamoto., Kenneth O’Byrne., Vera Hirsh. (2013) Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. Clin. Oncol., 31, 3335-3342; DOI: 10.1200/JCO.2012.45.0981.
37. Venkatesh T., Bodke Y. D. (2016) Synthesis, antimicrobial and antioxidant activity of chalcone derivatives containing thiobarbitone nucleus. Med. Chem., 6, 440-448; DOI:10.4172/2161-0444.1000383.
38. Sukanya S. H., Venkatesh T., Aditya rao S. J. (2022) Efficient L-Proline catalyzed synthesis of some new (4-substituted-phenyl)-1,5-dihydro-2H-pyrimido[4,5-d][1,3]thiazolo[3,2a]-pyrimidine-2,4(3H)-diones bearing thiazolopyrimidine derivatives and evaluation of their pharmacological activities. J. Mol. struct., 1247, 1-13; DOI: https://doi.org/10.1016/j.molstruc.2021.131324.
39. Anjan Kumar G. C., Bodke Y. D., Manjunatha B., Satyanarayana N. D. (2022) Chim. Techno. Acta., 9, 2411-1414; DOI:10.15826/chimtech.2022.9.1.04.